022 3036
UNITED STATES OF AMERICA
FEDERAL TRADE COMMISSION
In the Matter of
UNITHER PHARMA, INC.,
and
UNITED THERAPEUTICS CORPORATION. |
DOCKET NO.
|
COMPLAINT
The Federal Trade Commission, having reason to believe that Unither Pharma, Inc., a
corporation, and United Therapeutics Corporation, a corporation, have violated the provisions of the
Federal Trade Commission Act, and it appearing to the Commission that this proceeding is in the public
interest, alleges:
1. a. Respondent Unither Pharma, Inc. ("Unither Pharma")
is a Delaware corporation with its principal office or place of business
at 1110 Spring St., Silver Spring, Maryland 20910. Unither
Pharma is a wholly owned subsidiary of Unither Pharmaceuticals, Inc., which is
wholly owned by respondent United Therapeutics Corporation. Unither Pharma
markets and sells an L-arginine-based
dietary supplement and a purported medical food under the HeartBar brand name.
This dietary supplement purportedly treats or prevents cardiovascular disease
and/or improves endurance.
b. Respondent United Therapeutics Corporation ("United Therapeutics")
is a Delaware corporation with its principal office or place of business
at 1110 Spring St., Silver Spring, Maryland
20910. United Therapeutics participated in the advertising claims challenged
herein, including the
creation and dissemination of Exhibits H through J.
2. Respondents have advertised, offered for sale,
sold and distributed products to the public, including HeartBar, HeartBar
Plus, and HeartBar Sport. These products are "foods" and/or "drugs" within
the meaning of Sections 12 and 15 of the Federal Trade Commission Act.
3. The acts and practices of respondents alleged
in this complaint have been in or affecting
commerce, as "commerce" is defined in Section 4 of the Federal Trade Commission
Act.
4 Respondents have disseminated or have caused to be
disseminated advertisements for
HeartBar and HeartBar Plus (collectively "HeartBar") and HeartBar Sport, including
but not necessarily limited to the attached Exhibits A through J. Since at least
1999, advertisements and
promotions have appeared on the cookepharma.com and unither.com websites, on
product packaging,
and/or in print media, such as Reader's Digest, Modern Maturity, Prevention, The San Francisco
Chronicle, The Chicago Sun-Times, The Detroit Free Press, The Cleveland Plain Dealer, The
Miami Herald, and newspaper inserts published by News America Marketing FSI, Inc. HeartBar
products are sold in two forms, an edible bar and a powder, which is mixed with water. The bars have
sold for approximately $2 each. According to the product labels, HeartBar and HeartBar Sport
contain, among other ingredients, 3 to 6 grams of L-Arginine, soy isoflavones extract, Vitamins A, B-6,
B-12, C and E, niacin, folate, iron, and calcium. The advertisements for HeartBar contain the following
statements, among others:
Print Advertising:
A. Today people with heart disease are discovering
that taking two HeartBars a day is bringing welcome relief from heart
disease symptoms such as … leg pain - usually within the first two
weeks.
One HeartBar a day thereafter may be sufficient to
maintain results. …
Studies show that taking two HeartBars a day …
* * * *
Reduce[s] painful symptoms such as angina and leg pain
* * * *
(Ex. A) (Ex. A is a print advertisement for HeartBar).
B. Here's
what HeartBar can do…
Improve … heart health
* * * *
Reduce painful symptoms such as … leg pain
* * * *
(Ex. B) (Ex. B is a print advertisement for HeartBar).
Internet Advertising:
C. HeartBar® Plus contains 6 grams of arginine per serving, and it has
been shown in clinical trials to be effective in ... decreasing angina ...
in patients with coronary artery disease. In addition, HeartBar® Plus
may be of benefit to selected at-risk population of developing
cardiovascular disease.
(Ex. C at 1) (Ex. C consists of webpages from the cookepharma.com
website dated March 26, 2002).
D. Eating two HeartBars a day …:
• Reduces painful symptoms of heart disease such as … leg
pain
* * * *
• Helps improve ability to exercise without pain,
discomfort…
* * * *
Results are usually experienced within the first two weeks. After two
weeks, one HeartBar® may be sufficient to maintain results.
(Ex. D at 1) (Ex. D consists of webpages from the cookepharma.com website dated
August 20, 2001).
E. …Not to be mistaken for health bar look-alikes, new HeartBar® contains
a scientifically proven ingredient to reduce the pain … associated with
vascular disease … .
* * * *
Fifteen years of scientific research at major institutions
reveal that in certain patients the dietary use of the nutritional ingredients
in HeartBar®:
• Helps reverse the effects of high cholesterol,
smoking,
diabetes, and estrogen deficiency on the heart
* * * *
(Ex. C at 5-6) (Ex. C consists of webpages from the cookepharma.com
website dated March 26, 2002).
F. How does HeartBar® Work? … The active ingredients in HeartBar® have been clinically proven,
in properly selected patients, to … increase pain-free exercise
performance.
(Ex. C at 7) (Ex. C consists of webpages from the cookepharma.com website dated
March 26, 2002).
G. How many HeartBars should a consumer eat a day to
receive all of the heart and vascular benefits?
Clinical research shows that, for best results, … significant
improvement (66%) in pain free walking distance … [is] achieved
by eating two bars a day.
(Ex. D at 2) (Ex. D consists of webpages from
the cookepharma.com website dated
August 20, 2001).
H. HeartBar Sport is a line of L-arginine dietary supplements developed from our experience
with HeartBar Plus. HeartBar Sport contains 3 grams of arginine per serving, and it has
been shown in clinical trials to improve endurance and energy.
(Ex. C at 3) (Ex. C consists of webpages from the cookepharma.com website dated
March 26, 2002).
I. Who are HeartBar® products for?
* * * *
HeartBar® Sport, the dietary supplement, is intended
for
older adults or at-risk individuals who wish to maintain good
cardiovascular health, as well as benefit from increased
energy and endurance.
(Ex. C at 14-15) (Exhibit F consists of webpages from the cookepharma.com website
dated March 26, 2002).
J. The following testimonials from doctors have appeared on the cookepharma.com
website:
1. Doctor's Corner
____________________________________
John P. Cooke
Vascular Medicine
Stanford University School of Medicine
Stanford, CA
A Nutritional Approach to a Healthy Endothelium:Case
Histories
I have been studying the endothelium for the better
part of two
decades, first at Mayo where I was trained, then as an Assistant
Professor at Harvard, and now as Associate Professor and
Director of the NIH-funded Vascular Medicine Program at
Stanford. …
The HeartBar® has now been tested in rigorous,
double-blind,
placebo-controlled trials and has been shown to improve exercise
tolerance and reduce pain in patients with coronary and peripheral
arterial disease. Although these clinical trials are very gratifying,
what I find even more satisfying are the positive results that I have
observed in my own clinic. Here are a few representative
anecdotes:
* * * *
A 78 y/o male with intermittent claudication
L. M. is a vigorous 78 year old man who looks younger than his
stated age. As an alpine biologist, one of his classes each year
involved a month of hiking over the heights of Yosemite and King's
Canyon. Now, in retirement he is still an outdoorsman, and enjoys
outdoor activities with his son.
For the last few years though, he had noticed cramping in his legs
after walking up a hill. The discomfort would subside if he stood still
for a moment, and then he could go on. But about two years ago,
the cramping became a real disability for him. He was tightening up
after walking a half-mile, and he could only go that far if he walked
slowly. The great outdoors was getting farther away for LM.
He came to my Vascular Medicine clinic at Stanford in the spring of
1999. I prescribed Trental 400 tid. He returned to me 6 weeks
later with little improvement. At that point I stopped the Trental and
introduced him to the HeartBar. LM began taking two bars daily. It
wasn't long before he noticed an improvement, and over time, he
continued to improve. At the time of this writing, LM is able to
walk faster, without pain, and considers himself unlimited. He is
even able to jog a quarter of a mile before he needs to slow down.
He's back to the hills, and enjoying the outdoors again with his son.
I hope that you found these anecdotes interesting. I welcome you to
send in your own anecdotes regarding your experience with this
nutritional therapy.
With warmest regards,
John P. Cooke, MD Ph.D.
Associate Professor and Director
Section of Vascular Medicine
Stanford University School of Medicine
____________________________________
2. Doctor's Corner
____________________________________
Alan S. Bailer
Cardiovascular Diseases
1330 Cottman Ave.
Philadelphia, PA 19111
Patient Success Story
My 77 year old father had a triple coronary artery
bypass grafting
procedure in 1984. …
* * * *
I am convinced that, without the HeartBars, my father would have
had to undergo another revascularization. Thank you, Cooke
Pharma, for this wonderful product.
____________________________________
3. Doctor's Corner
____________________________________
Marcus S. Kryger
Box 280
Forsyth, MO 65653
PVD Patient Success Stories
- 82 Year old white female with ischemic cardiomyopathy
and
severe peripheral vascular disease by IMEX scan. Unable to
walk 1 block due to leg pain and dyspnea. She was
scheduled for femoral artery bypass, but started on HeartBar.
Three months later, without surgery or other medical changes,
she was walking 2 miles daily and continues to do so, without
symptoms, 15 months later.
* * * *
- 86 Year old white male with CHF due to ischemic
cardiomyopathy and severe leg pain on walking over 50 feet.
Started on HeartBar BID, no other changes in medical
regime. A month later he repaired his roof by himself without
any symptoms. He felt well for 4 months then stopped
HeartBar. He rapidly became more dyspneic; restarted
HeartBar BID with prompt improvement and went deer
hunting this past fall.
____________________________________
4. Doctor's Corner
____________________________________
Peter Gray
90 South St.
Glens Falls, NY 12801
Great Results--Reducing Angina Episodes, Claudication…
Great results regarding:
* * * *
I'm now using it with my father for claudication with excellent results.
____________________________________
(Ex. C at 8-13) (Ex. C consists of webpages from the cookepharma.com
website dated March 26, 2002).
K. The following testimonials from HeartBar customers have appeared on the
cookepharma.com website:
1. Mary R. Gompf from OH
"It was just like my Doctor said. After only 2 weeks of taking the
HeartBar, I noticed a dramatic reduction in my … leg pain. …Thank
you."
2. Mr. Barry Dangler from FL
"…My Cardiologist has taken me off of Imdur for my
angina pain
now that I'm taking the HeartBar. I feel great."
3. Ms. Betty Burke from CA
"I had severe burning pain in my left leg when I ran
up hills. My AB Index, done by Stanford Research, in my left leg
was only .5. I read
on the Internet that a .4 Index might require amputation. After 2
weeks taking the HeartBar, the burning pain is gone! I can run with
no pain. I also don't have any leg pain when playing tennis. I was
seen by a vascular surgeon who proclaimed that I had excellent
circulation in both legs. HeartBar has really changed my life!"
4. Mr. Sam Roska from CA
"I have atherosclerosis in both legs. After 2 angioplasties
on my legs, my doctor put me on HeartBar. Further angioplasty presented
a 20% risk of amputation. I had been able to walk only up to about 3
minutes before debilitating leg pain forced me to stop. After about a
month on the HeartBar, I was able to walk 10 minutes with no pain! I
now have much less pain than before."
5. Thomas Overbeek from MI
"I have had leg pains for about 10 years. The pain in my left leg
became especially bad in the last 6 months. I could barely walk from
the bedroom to the bathroom. I couldn't stand up without pain.
Because of my worsening condition, I was scheduled for bypass
surgery in my leg. My doctor told me my pain would remain,
however. But, after 2 weeks taking the HeartBar, the pain in my leg
disappeared. It was unbelievable! As scheduled, I went into see my
surgeon the day before my surgery; he cancelled the surgery. I
haven't felt this good in 10 years. I can walk and climb stairs with no
pain now, and can stand for half an hour. …"
6. Al White from MI
"I am almost an Octogenarian (in 6 months)…. I have
not had to use my Nitro-Stat pills since I started using HeartBars--not
a single one.
I got my Doctor's OK first to use the HeartBars."
(Ex. C at 16-18) (Exhibit F consists of webpages from the
cookepharma.com website dated March 26, 2002).
Packaging:
L. Front panel:
HeartBar
Plus
6g
L-Arginine per Bar
Clinically Proven Results
* * * *
Reduces angina and leg pain
(Ex. C at 2) (Ex. C consists of webpages from the cookepharma.com
website dated March 26, 2002; page 2 depicts packaging for HeartBar
Plus).
M. Front panel:
HeartBar
* * * *
Recommended
by Doctors for Daily Use
* * * *
• Helps Reduce… Leg Pain
* * * *
Back panel:
If you have heart disease, take two HeartBars
a day to feel a difference within two weeks.
Eating
two HeartBars a day helps … with the following results:
• Reduces painful symptoms of heart disease such as … leg
pain
****
• Helps improve ability to
exercise without pain, discomfort …
****
(Ex. E at 1-2; citation omitted) (Ex. E is a
copy of the packaging for
HeartBar).
N. Front Panel:
HeartBar
Sport
Dietary Supplement
3g L-Arginine per Serving
Clinically Proven Results
Improves
endurance… and energy[]
(Ex. F; citation omitted) (Ex. F is a copy of
the front of the packaging for
HeartBar Sport from 2002).
Other Promotions:
O. Is
HeartBar® Right for You?
* * * *
If you are elderly, you might want to consider that
as we age, our need for arginine in the diet increases. Eaten in the
right amount, arginine can help
prevent a variety of age-related vascular problems, including "hardening of
the arteries" and plaque formation, and prevent or reverse the symptoms
associated with them. …
(Ex. G at 2) (Ex. G is an excerpt from the jewel case insert for The Heart of
the Classics musical Compact Disc given to HeartBar distributors).
P. …[E]ating HeartBar® products … can improve your aerobic performance.
For these reasons, even those who are not experiencing heart disease or
age-related symptoms choose to make HeartBar® part of their daily
regimen.
Clinical
Research Confirms that HeartBar® …
* * * *
Relieves painful symptoms such as
angina and leg pain.
* * * *
(Ex. G at 3) (Ex. G is an excerpt
from the jewel case insert for The Heart of
the Classics musical Compact Disc given to HeartBar distributors).
Q. See Results in Two Weeks!
In clinical studies, after only two weeks
of eating two HeartBars® daily,
patients showed significant improvement in angina scores ....[] In
patients
suffering from PAD (peripheral artery disease), HeartBar® was shown to
significantly improve the ability to walk pain free.[] After the
initial two
weeks, one HeartBar® a day may be sufficient to maintain these results.
* * * *
70% reduction in angina pain
66% increase in ability to exercise
(Ex. G at 4; citations omitted) (Ex. G is an excerpt from the jewel case insert
for The Heart of the Classics musical Compact Disc given to HeartBar
distributors).
R. "In my experience, recommending Heart Bar has helped
to stop heart
disease in my patients."
Joe Predergast, M.D.
Diabetes Specialist
(Ex. H. at 2; Ex. K is an excerpt from the 2001 United Therapeutics
Corporation Annual Report).
S. HeartBar
… Clinical studies conducted by Cooke Pharma have demonstrated
the ability of the HeartBar to reduce painful symptoms associated
with cardiovascular diseases …. Randomized, double-blinded
clinical studies published in medical journals and presented at the
2000 American Heart Association meeting have shown that the
HeartBar works. …
(Ex. I. at 2; Ex. I is an excerpt from the 2000 United Therapeutics
Corporation Annual Report).
T. United Therapeutics Acquiring Cooke Pharma, Expanding into Angina and Coronary Artery
Disease
Silver Spring, MD and Belmont, CA, December 18, 2000 -
* * * *
…Clinical studies conducted by Cooke Pharma have demonstrated convincingly the
ability of the HeartBar to reduce painful symptoms of cardiovascular disease…. …
(Ex. J at 1; Ex. J is a December 18, 2000, press release from the
unitedtherapeutics.com website).
5. Through the means described in Paragraph 4, respondents have represented, expressly or by
implication, that:
A. HeartBar substantially decreases leg pain for people with cardiovascular disease;
B. HeartBar reverses damage or disease to the heart caused by high cholesterol, smoking,
diabetes, or estrogen deficiency;
C. HeartBar prevents age-related vascular problems,
including "hardening of the arteries" and plaque formation, and reduces
the risk of developing cardiovascular disease;
D. HeartBar reduces or eliminates the need for surgery, such as a coronary bypass or
angioplasty, and medications, such as nitroglycerin, in patients with cardiovascular
disease; and
E. HeartBar Sport improves endurance and energy for the general population.
6. Through the means described in Paragraph 4, respondents have represented, expressly or by
implication, that they possessed and relied upon a reasonable basis that substantiated the representations
set forth in Paragraph 5, at the time the representations were made.
7. In truth and in fact, respondents did not possess and rely upon a reasonable basis that
substantiated the representations set forth in Paragraph 5, at the time the representations were made.
Several of the representations are not supported by any clinical studies on humans. Other
representations are based on results reported in studies that suffer from various flaws, including the
failure to account for the placebo effect and extremely small sample sizes, such that the experience of a
single or a few subjects account for the benefits purportedly experienced by the active group as a whole.
Therefore, the representation set forth in Paragraph 6 was, and is, false or misleading.
8. Through the means described in Paragraph 4, respondents have represented, expressly or by
implication, that clinical studies, research, and/or trials show that:
A. HeartBar decreases angina pain, including by as much as 70% within two weeks;
B. HeartBar decreases leg pain while walking or exercising, including by as much as 66%
within two weeks, for people with peripheral artery disease;
C. HeartBar reverses the effects of high cholesterol, smoking, diabetes, and estrogen
deficiency on the heart; and
D. HeartBar Sport improves endurance and energy for the general population.
9. In truth and in fact, clinical studies, research, and/or trials do not show that:
A. HeartBar decreases angina pain, including by as much as 70% within two weeks;
B. HeartBar decreases leg pain while walking or exercising, including by as much as 66%
within two weeks, for people with peripheral artery disease;
C. HeartBar reverses the effects of high cholesterol, smoking, diabetes, and estrogen
deficiency on the heart; or
D. HeartBar Sport improves endurance and energy for the general population.
Therefore, respondents' representations set forth in Paragraph 8, above, were, and are, false or
misleading.
10. The acts and practices of respondents as alleged in this complaint constitute unfair or deceptive
acts or practices, and the making of false advertisements, in or affecting commerce in violation of
Sections 5(a) and 12 of the Federal Trade Commission Act.
THEREFORE, the Federal Trade Commission this day of , 2003, has issued this
complaint against respondents.
By the Commission.
Donald S. Clark
Secretary
SEAL:
|